CA2238460A1 - Compositions immunomodulantes pour le traitement de troubles attribuables aux virus - Google Patents

Compositions immunomodulantes pour le traitement de troubles attribuables aux virus Download PDF

Info

Publication number
CA2238460A1
CA2238460A1 CA002238460A CA2238460A CA2238460A1 CA 2238460 A1 CA2238460 A1 CA 2238460A1 CA 002238460 A CA002238460 A CA 002238460A CA 2238460 A CA2238460 A CA 2238460A CA 2238460 A1 CA2238460 A1 CA 2238460A1
Authority
CA
Canada
Prior art keywords
antiviral
composition
use according
virus
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002238460A
Other languages
English (en)
Inventor
Paul Percheson
Romeo Rang (Deceased)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aptose Bioscience Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002206047A external-priority patent/CA2206047A1/fr
Application filed by Individual filed Critical Individual
Priority to CA002238460A priority Critical patent/CA2238460A1/fr
Publication of CA2238460A1 publication Critical patent/CA2238460A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/413—Gall bladder; Bile
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002238460A 1997-05-23 1998-05-22 Compositions immunomodulantes pour le traitement de troubles attribuables aux virus Abandoned CA2238460A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002238460A CA2238460A1 (fr) 1997-05-23 1998-05-22 Compositions immunomodulantes pour le traitement de troubles attribuables aux virus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,206,047 1997-05-23
CA002206047A CA2206047A1 (fr) 1997-05-23 1997-05-23 Compositions immunomodulantes pour le traitement de troubles attribuables aux virus
CA002238460A CA2238460A1 (fr) 1997-05-23 1998-05-22 Compositions immunomodulantes pour le traitement de troubles attribuables aux virus

Publications (1)

Publication Number Publication Date
CA2238460A1 true CA2238460A1 (fr) 1998-11-23

Family

ID=25679364

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002238460A Abandoned CA2238460A1 (fr) 1997-05-23 1998-05-22 Compositions immunomodulantes pour le traitement de troubles attribuables aux virus

Country Status (1)

Country Link
CA (1) CA2238460A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111655267A (zh) * 2018-01-30 2020-09-11 维也纳医科大学 预防或治疗鼻病毒感染的药物
CN114306350A (zh) * 2022-01-13 2022-04-12 四川大学华西医院 胆固醇硫酸盐在制备预防脓毒症的药物中的用途

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111655267A (zh) * 2018-01-30 2020-09-11 维也纳医科大学 预防或治疗鼻病毒感染的药物
CN111655267B (zh) * 2018-01-30 2023-06-20 维也纳医科大学 预防或治疗鼻病毒感染的药物
CN114306350A (zh) * 2022-01-13 2022-04-12 四川大学华西医院 胆固醇硫酸盐在制备预防脓毒症的药物中的用途
CN114306350B (zh) * 2022-01-13 2023-01-24 四川大学华西医院 胆固醇硫酸盐在制备预防脓毒症的药物中的用途

Similar Documents

Publication Publication Date Title
KR100416335B1 (ko) 내독소혈증의치료및예방에유용한치환지당류
ES2214551T3 (es) Terapia de infusion continua de citocinas a baja dosis.
US20060029573A1 (en) Pegylated interferon alpha-1b
CA2582027A1 (fr) Composition pharmaceutique pour le traitement de pathologies causees par la reponse generale du systeme immunitaire
JP2004510698A (ja) フラビウイルスおよびペスチウイルス治療のための方法および組成物
UA44223C2 (uk) Спосіб лікування пацієнтів, які страждають на саркому капоші, спосіб лікування пацієнтів, які страждають на гепатит с, препарат для лікування пацієнтів, які страждають на саркому капоші, препарат для лікування пацієнтів, які страждають на вірусний гепатит с
JP5031162B2 (ja) ウイルス感染を二重ターゲティングおよびガン細胞をターゲティングするための組成物および方法
US6596319B2 (en) Immunomodulating compositions for treatment of immune system disorders
KR100589022B1 (ko) 항바이러스성 선형 중합체
US6280774B1 (en) Immunomodulating compositions from bile
US20080279957A1 (en) Immunomodulating compositions from bile
RU2104032C1 (ru) Способ усиления лечебного эффекта лекарственных средств
CA2388005A1 (fr) Ifn-gamma a faibles doses destine au traitement de maladies
CA2238460A1 (fr) Compositions immunomodulantes pour le traitement de troubles attribuables aux virus
WO2019066590A1 (fr) Peptide dérivé de zag et son utilisation
EP1541153A1 (fr) Inhibiteur du virus de l'hepatite c comprenant l'alpha-glycosylceramide comme ingredient actif
ES2260790T3 (es) Estimulacion de los mecanismos de defensa del huesped contra los ataques virales.
JP4580479B2 (ja) 抗ｈｉｖ感染症剤
CA2206047A1 (fr) Compositions immunomodulantes pour le traitement de troubles attribuables aux virus
US6551623B1 (en) Immunomodulating compositions from bile
JP4606715B2 (ja) 免疫活性増強剤、並びにそれが含まれた食品および医薬部外品
US20070123467A1 (en) Amniotic-derived peptide and uses thereof
Müller et al. Interleukin-1 production in acute viral hepatitis.
KR20010108040A (ko) 항-ｈｉｖ 감염증제 및 ｈｉｖ 감염증의 치료 방법
US6495678B1 (en) Immunosuppressant containing glucopyranose derivative as active ingredient

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead